Chemoinformaics analysis of 4-O-Methylglucuronic acid
| Molecular Weight | 208.166 | nRot | 6 |
| Heavy Atom Molecular Weight | 196.07 | nRig | 2 |
| Exact Molecular Weight | 208.058 | nRing | 0 |
| Solubility: LogS | -0.137 | nHRing | 0 |
| Solubility: LogP | -2.165 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 6 | APOL | 25.3055 |
| nHD | 4 | BPOL | 15.5105 |
| QED | 0.267 |
| Synth | 4.078 |
| Natural Product Likeliness | 1.116 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.028 |
| HIA | 0.901 |
| CACO-2 | -5.506 |
| MDCK | 0.00370194 |
| BBB | 0.859 |
| PPB | 0.185803 |
| VDSS | 0.283 |
| FU | 0.770803 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.039 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.002 |
| CYP2c9-sub | 0.034 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.095 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.028 |
| CL | 1.619 |
| T12 | 0.825 |
| hERG | 0.078 |
| Ames | 0.231 |
| ROA | 0.012 |
| SkinSen | 0.215 |
| Carcinogencity | 0.009 |
| EI | 0.025 |
| Respiratory | 0.437 |
| NR-Aromatase | 0.008 |
| Antiviral | No |
| Prediction | 0.874929 |